stars 1 stars 2 stars 3

SARA Pharm is the contract lab of choice for solid form screening & crystallization studies. Founded in 2011, we provide services worldwide having clients (till now) on all continents except Antarctica and South America. In our studies we use a large number of experiments of various types plus many crystallization conditions to find as many crystalline forms as possible, for IP protection and also to determine the most suitable solid form for further development. At the end of each study we scale-up to grams scale and determine the easiest and most cost-efficient method for producing the desired solid, to be further refined for production. We can perform pre-formulation studies that increase the chances in obtaining a strong understanding of the API properties such as solubility, stability and its compatibility with excipients. We are authorized to work with controlled substances too (narcotic drugs and psychotropic substances).

SARA Pharm Solutions Questions

The SARA Pharm Solutions annual revenue was $6.7 million in 2026.

Eugenia Mihalcea is the CEO of SARA Pharm Solutions.

2 people are employed at SARA Pharm Solutions.

The NAICS codes for SARA Pharm Solutions are [32, 325, 3254, 32541].

The SIC codes for SARA Pharm Solutions are [283, 28].

Top SARA Pharm Solutions Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users